|
|
 |
|
 |
 |
|
|
|
|
|
|
|
 
|
|
2010 Approved Projects
|
|
No. 1
|
NNCAS-2010-1
|
|
Type and Fund
|
Joint search project |
|
Title
|
High throughput screening for the cell surface markers/drug targets of xxx and their corresponding antibodies
|
|
CAS applicant
|
Hang Haiying, Principal investigator and Chief expert, Center for Computational and Systems Biology and Flow cytometry core, Institute of Biophysics, CAS
|
| NN applicant |
Li Hanfen, Scientist, Department of Cell Biology, Beijing Novonordisk Pharmaceuticals Science and Technology Co., Ltd |
|
|
|
|
No. 2
|
NNCAS-2010-2
|
|
Type and Fund
|
Joint search project |
|
Title
|
Targeting xxx to regulate xxx inflammasome associated Autoimmune and Autoinflammatory diseases
|
|
CAS applicant
|
MENG GUANGXUN, Principal Investigator, Unit of Innate Immunity, Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences
|
|
NN applicant
|
Kang Lishan, Associate Scientist, Molecular Biology Department, Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd (NNST) |
|
|
|
|
No. 3
|
NNCAS-2010-3
|
|
Type and Fund
|
Joint search project |
|
Title
|
The function of the xxx in the Diabetes pathogenesis
|
|
CAS applicant
|
Qin Yan, Professor, Institute of Biophysics
|
|
NN applicant
|
Zhang Xujia, Senior Scientist in Beijing Novo Nordisk Pharmaceuticals Science and Technology Co.,Ltd (NNST)
|
|
|
|
|
No. 4
|
NNCAS-2010-5
|
|
Type and Fund
|
Joint search project |
|
Title
|
Comprehensive Biomarker Analysis in Arthritis and Build-up of Bio-repository
|
|
CAS applicant
|
Jiang Xingyu, Professor, National Center for Nano Science &Technology
|
|
NN applicant
|
Yang Li, Scientist, Department of Cell Biology, Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd
|
|
|
|
|
No. 5
|
NNCAS-WS-2010-1
|
|
Type and Fund
|
Workshop and symposium |
|
Title
|
NN-CAS workshop on Translational Diabetes Research in China
|
|
CAS applicant
|
Jia-Rui Wu, Professor; Vice president of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
|
|
NN applicant
|
Marianne Oelholm Larsen Groenning，Director, Diabetes Research China, Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd
|
|
|
|
|
No. 6
|
NNCAS-PhD-2010-1
|
|
Type and Fund
|
Ph.D. fellowship
|
|
Title
|
Development and validation of label-free T Cell activation assays
|
|
PhD Student
|
Ms. Guan Ni, Graduate student, Shanghai Institute of Material Medica, Chinese Academy of Sciences
|
|
CAS applicant
|
A dissertation group consisting of both internal and external advisors:
- XU XIAO, Adjunct Professor of Pharmacology, the National Center for Drug Screening, Shanghai Institute of Material Medica, CAS and President, Acea Biosciences Inc., USA
- WANG MING-WEI, Director, the National Center for Drug Screening and Professor of Pharmacology, Shanghai Institute of Material Medica, CAS and President, Acea Biosciences Inc., USA
- JEFFERY IRELAN, Research Scientists, ACEA Biosciences Inc., USA
|
|
NN applicant
|
ZHANG JUN, Principal Scientist, Beijing Novonordisk Pharmaceuticals Science and Technology Co., Ltd.
|
|
|
|
|
No. 7
|
NNCAS-PhD-2010-2
|
|
Type and Fund
|
Ph.D. fellowship
|
|
Title
|
Interaction matrix of xxx and its xxx signalling modulating mechanism |
|
PhD Student
|
- PhD student, Novo Nordisk Foundation Center for Protein Research
- TING LI, Graduate student, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences
|
|
CAS applicant
|
- MATS WIKSTRÖM, Project Manager, Novo Nordisk Foundation Center for Protein Research;
- WANG MING-WEI, Director, the National Center for Drug Screening and Professor of Pharmacology, Shanghai Institute of Material Medica, CAS and President, Acea Biosciences Inc., USA
|
|
NN applicant
|
Michael Christian Gerstenberg, Principal Scientist, Novo Nordisk A/S
|
|
|
No. 8
|
NNCAS-PostDoc-2010-1
|
|
Type and Fund
|
Post-doc fellowship
|
|
Title
|
The effects of soluble xxx-family ligands on human xxx cells: a potential therapeutic tool against rheumatoid arthritis
|
|
Applicant
|
Andy Tsun, Postdoctoral Research Fellow, Unit of Molecular Immunology, Laboratory of Professor Bi Li, Institut Pasteur of Shanghai, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences |
|
CAS host
professor
|
Professor Bin Li, Professor, Principal Investigator, Institut Pasteur of Shanghai, Chinese Academy of Sciences
|
|
NN host
professor
|
Dr. Luo Yi, Scientist in Protein Chemistry Department at Beijing Novo Nordisk Pharmaceuticals Science and Technology Co., Ltd.
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
|
 |
|
 |
|
|
|
诺和诺德(中国)制药有限公司
联系我们
网站地图
